ArticleDrugs in context2024

Anti-IL-17 monoclonal antibodies and bullous pemphigoid: treatment or causal agents? A case series and review of the literature.

Anna Paola Lugli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.